Gene vaccination to bias the immune response to amyloid-β peptide as therapy for Alzheimer disease

Archives of Neurology

Volumn 61, Issue 12, 2004, Pages 1859-1864

  Qu, Baoxi ^a   Rosenberg, Roger N ^a   Li, Liping ^a   Boyer, Philip J ^a   Johnston, Stephen A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PLASMID DNA;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE GUN; GENE VACCINATION; GENETIC IMMUNIZATION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TRANSGENIC MOUSE; VACCINATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; VACCINES, DNA;

EID: 10044263401     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.12.1859     Document Type: Article

References (26)

1. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease: hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann N Y Acad Sci. 2000;924:17-25.
2. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741-766.
3. Hardy J. Amyloid, the preseniline and Alzheimer's disease. Trends Neurosci. 1997;20:154-159.
4. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 1999;399(6738 suppl):A23-A31.
5. Monsonego A, Weiner HL. Immunotherapeutic approaches to Alzheimer's disease. Science. 2003;302:834-838.
6. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Molecular pathways to neurodegeneration. Nat Med. 2004;10(suppl):S2-S9.
7. Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400:173-177.
8. Kotilinek LA, Bacskai B, Westerman M, et al. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci. 2002;22:6331-6335.
9. Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid-beta peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916-919.
10. Hock C, Konietzko U, Papassotiropoulos A, et al. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer's disease. Nat Med. 2002;8:1270-1275.
11. Hock C, Konietzko U, Streffer JR, et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron. 2003;38:547-554.
12. Qu B, Rosenberg RW, Johnston SA. Genetic Immunization approach for therapy of Alzheimer disease [abstract]. Neurobiol Aging. 2004;25(suppl):S568- S569.
13. Chambers RS, Johnston SA. High-level generation of polyclonal antibodies by genetic immunization. Nat Biotechnol. 2003;21:1088-1092.
14. de Arruda LB, Chikhlikar PR, August JT, Marques ET. DMA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response. Immunology. 2004;112:126-133.
15. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature. 1992;356:152-154.
16. Kumar A, Weiss W, Tine JA, Hoffman SL, Rogers WO. ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques. J Immunol Methods. 2001;247:49-60.
17. Borchelt DR, Ratovitski T, van Lare J, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997;19:939-945.
18. Lehman EJ, Kulnane LS, Gao Y, et al. Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse. Hum Mol Genet. 2003;12:2949-2956.
19. Guo-Ross SX, Yang EY, Walsh TJ, Bondy SC. Decrease of glial fibrillary acidic protein in rat frontal cortex following aluminum treatment. J Neurochem. 1999;73:1609-1614.
20. Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature. 1995;377:632-635.
21. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993;259:1745-1749.
22. Ji H, Wang TL, Chen CH, et al. Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-exprssing tumors. Hum Gene Ther. 1999;10:2727-2740.
23. Schultz JG, Salzer U, Mohajerl MH, et al. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease. J Mol Med [online series]. Available at: http://www. 2004;0570-z.
24. Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 1997;158:2278-2284.
25. Weiss R, Scheiblhofer S, Freund J, et al. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA. Vaccine. 2002;20:3148-3154.
26. Solomon B. Alzheimer's disease and immunotherapy. Curr Alzheimer Res. 2004;1:149-163.